XIB in the WHO classification of xerophthalmia refers to which of the following?
Which of the following is not included in the 'SAFE' strategy?
Which of the following is NOT a component of the SAFE strategy?
What was the number of centers of excellence in vision in the year 2020?
Follow-up of cataract operations in the national blindness control program is done by which method?
Which Indian state has the highest prevalence of blindness in rural areas?
Which of the following is NOT a criterion for establishing the presence of endemic trachoma in a community?
What is the most common operation performed by an ophthalmologist in a district hospital?
What percentage of disability can be certified for a patient with 1/60 vision in one eye and 6/60 vision in the other eye?
Which of the following is NOT included in the Vision 2020 - The Right to Sight initiative?
Explanation: ### Explanation The WHO classification of Xerophthalmia is a high-yield topic in Community Ophthalmology, used to grade the severity of Vitamin A deficiency. **Why Bitot Spots (X1B) is correct:** The WHO classification categorizes Vitamin A deficiency into specific stages. **X1B** specifically refers to **Bitot’s spots**, which are triangular, foamy, silvery-white patches found on the bulbar conjunctiva (usually temporal). They represent keratinization of the conjunctival epithelium due to a lack of Vitamin A, which is essential for maintaining mucus-secreting goblet cells. **Analysis of Incorrect Options:** * **A & B (Sclerosis):** Sclerosis (hardening) is not a standard term used in the WHO xerophthalmia classification. The stages involve dryness (Xerosis), not sclerosis. **X1A** refers to Conjunctival Xerosis, while **X2** refers to Corneal Xerosis. * **D (Corneal Ulceration):** This occurs in later stages. **X3A** refers to corneal ulceration/keratomalacia involving less than 1/3rd of the corneal surface, while **X3B** involves more than 1/3rd. **WHO Classification Summary (High-Yield for NEET-PG):** * **X1A:** Conjunctival xerosis * **X1B:** Bitot’s spots * **X2:** Corneal xerosis * **X3A:** Corneal ulceration/Keratomalacia (<1/3rd cornea) * **X3B:** Corneal ulceration/Keratomalacia (>1/3rd cornea) * **XN:** Night blindness (earliest clinical symptom) * **XF:** Xerophthalmic fundus (white dots on retina) * **XS:** Corneal scars (sequelae of healed ulcers) **Clinical Pearl:** Night blindness (**XN**) is the earliest *symptom*, while Conjunctival Xerosis (**X1A**) is the earliest *clinical sign*. Bitot's spots are reversible with Vitamin A therapy, but stages X3A and X3B are medical emergencies that can lead to permanent blindness.
Explanation: The **SAFE strategy** is a comprehensive public health approach developed by the World Health Organization (WHO) to eliminate **Trachoma** (caused by *Chlamydia trachomatis* serotypes A, B, Ba, and C) as a cause of blindness. ### **Explanation of the Correct Answer** **A. Supplementation of vitamins:** This is the correct answer because vitamin supplementation (specifically Vitamin A) is a strategy used for **Xerophthalmia** and nutritional blindness, not Trachoma. While nutrition is important for general health, it is not a formal component of the SAFE acronym. ### **Explanation of Incorrect Options (Components of SAFE)** * **S – Surgery:** For trichiasis (in-turned eyelashes) to prevent corneal scarring and subsequent blindness. * **A – Antibiotics:** Specifically the use of **Azithromycin** (single dose) or Tetracycline eye ointment to treat the active infection and reduce the community reservoir. * **F – Facial cleanliness:** Encouraging regular face washing to reduce the spread of infected ocular and nasal secretions. * **E – Environmental improvement:** Improving access to water and sanitation (e.g., latrine construction) to reduce the breeding of *Musca sorbens* (the eye-seeking fly) which acts as a vector. ### **High-Yield Clinical Pearls for NEET-PG** * **Target:** The WHO "GET2020" initiative aimed to eliminate trachoma by 2020; many countries are now in the surveillance phase. * **Drug of Choice:** Oral **Azithromycin** (20 mg/kg up to 1g) is the preferred treatment in the SAFE strategy. * **Mass Drug Administration (MDA):** Indicated if the prevalence of follicular trachoma (TF) is **>5%** in children aged 1–9 years. * **Vector:** The common housefly (*Musca domestica*) and the eye fly (*Musca sorbens*) are the primary mechanical vectors. * **Grading:** Remember the **WHO FIST grading** (Follicular, Intense, Scarring, Trichiasis, Corneal Opacity).
Explanation: The **SAFE strategy** is a comprehensive public health approach recommended by the WHO for the global elimination of **Trachoma** (caused by *Chlamydia trachomatis*). ### Why "Screening" is the Correct Answer The letter **'S'** in the SAFE acronym stands for **Surgery**, not Screening. While screening is a general public health activity, it is not a formal component of this specific management protocol. The goal of the 'S' component is to provide surgical correction (typically Bilamellar Tarsal Rotation) for individuals suffering from **trachomatous trichiasis** to prevent corneal opacity and blindness. ### Explanation of Incorrect Options * **Antibiotics (A):** This refers to the mass distribution of antibiotics (specifically **Azithromycin** 20mg/kg single dose or Tetracycline 1% eye ointment) to the entire community to treat active infection and reduce the reservoir of *C. trachomatis*. * **Facial hygiene (F):** This focuses on encouraging children and adults to wash their faces regularly. Clean faces reduce the transmission of infected ocular and nasal secretions. * **Environmental modification (E):** This involves improving access to clean water, proper sanitation, and **fly control** (specifically *Musca sorbens*), as flies are the primary mechanical vectors for the disease. ### High-Yield Clinical Pearls for NEET-PG * **Target Goal:** The WHO aims for the Global Elimination of Trachoma by the year **2030**. * **Vector:** *Musca sorbens* (the eye-seeking fly) is the most common vector. * **Drug of Choice:** Oral Azithromycin (Single dose) is the preferred treatment in the SAFE strategy. * **Trachoma Grading:** Remember the **WHO FISTO classification** (Follicular, Intense, Scarring, Trichiasis, Opacity) for clinical staging.
Explanation: This question pertains to the **NPCBVI (National Programme for Control of Blindness and Visual Impairment)** and its strategic infrastructure goals under the **Vision 2020: The Right to Sight** initiative. ### **Explanation** The "Vision 2020" global initiative, adopted by India, established a four-tier pyramidal model for eye care delivery to eliminate avoidable blindness. At the apex of this pyramid are the **Centers of Excellence (CoE)**. * **The Goal:** The target was to establish **20 Centers of Excellence** across India by the year 2020. * **Function:** These centers (e.g., AIIMS, RP Centre) serve as tertiary referral units, providing sub-specialty care, conducting high-level research, and training human resources for the lower tiers of the pyramid. ### **Analysis of Options** * **A (20):** Correct. This represents the apex tier (1 per 50 million population). * **B (200):** Incorrect. This number corresponds to the target for **Training Centers/Tertiary Eye Care Centers** (1 per 5 million population). * **C (2000):** Incorrect. This was the target for **Service Centers/District Eye Units** (1 per 0.5 million population). * **D (20000):** Incorrect. This was the target for **Vision Centers** (Primary level; 1 per 50,000 population). ### **High-Yield Clinical Pearls for NEET-PG** * **The Pyramid Model (Vision 2020):** 1. **Centers of Excellence (20):** Apex; Research and Training. 2. **Tertiary Centers (200):** Comprehensive eye care and specialty services. 3. **Secondary Centers (2000):** District level; Cataract surgeries and basic specialty care. 4. **Vision Centers (20,000):** Primary level; Refraction and primary eye care. * **Current Prevalence:** As per the National Blindness and Visual Impairment Survey (2015-19), the prevalence of blindness in India has reduced to **0.36%**. * **Definition Change:** Under NPCBVI, blindness is now defined as visual acuity **<3/60** in the better eye (previously <6/60), aligning with WHO standards.
Explanation: ### Explanation **Correct Answer: C. Sentinel Surveillance** In the context of the **National Programme for Control of Blindness and Visual Impairment (NPCBVI)**, follow-up of cataract surgeries is conducted via **Sentinel Surveillance**. **Why Sentinel Surveillance?** Sentinel surveillance involves the collection of high-quality data from a selected group of specialized sites (e.g., medical colleges or regional institutes) rather than every single health center. In cataract surgery, this method is used to monitor **post-operative outcomes and complications** (like endophthalmitis or visual acuity results). It provides a representative sample of the quality of surgical services provided across the country, allowing for "early warning" of systemic issues without the logistical burden of tracking every patient nationwide. **Analysis of Incorrect Options:** * **A. Active Surveillance:** This involves health workers actively visiting communities to identify cases (e.g., searching for fever cases in Malaria). It is not the standard for monitoring surgical outcomes in NPCBVI. * **B. Passive Surveillance:** This relies on patients voluntarily reporting to health facilities. While common in routine OPDs, it is insufficient for the structured quality monitoring required for cataract programs. * **D. Routine Check-up:** This is a clinical term for individual patient care, not a public health surveillance methodology used for program evaluation. **High-Yield Clinical Pearls for NEET-PG:** * **NPCB Target:** The current goal is to reduce the prevalence of blindness to **0.3% by 2025**. * **Definition of Blindness (NPCB):** Visual acuity < 3/60 in the better eye with best possible correction. * **Cataract Surgery:** It is the most cost-effective health intervention. Under NPCB, the focus has shifted from "quantity" (number of surgeries) to "quality" (visual outcome), which is why sentinel surveillance is vital. * **Sentinel Sites:** These are designated centers that report on the **Visual Outcome** of cataract surgery at 1-4 weeks post-operatively.
Explanation: **Explanation:** The prevalence of blindness in India is monitored through the **National Blindness and Visual Impairment Survey (2015-2019)**. According to this data, **Odisha** reports the highest prevalence of blindness in rural areas (approximately 2.13%). This is attributed to a combination of demographic factors, such as a higher proportion of the geriatric population in rural pockets, and geographical barriers that limit access to tertiary eye care services, leading to a high backlog of untreated cataracts. **Analysis of Options:** * **Odisha (Correct):** It leads the country in rural blindness prevalence. The primary cause remains untreated cataract, followed by corneal opacities and glaucoma. * **Bihar:** While Bihar has a high burden of eye diseases due to socioeconomic factors, its prevalence rates in the latest survey were lower than those of Odisha and Bijnor/Saharanpur clusters. * **Uttar Pradesh:** Although UP has the highest *absolute number* of blind individuals due to its massive population, the *prevalence rate* (percentage) is not the highest. * **Chhattisgarh:** While it faces challenges with tribal health and vitamin A deficiency, it does not surpass Odisha in the overall prevalence of adult blindness. **High-Yield Clinical Pearls for NEET-PG:** * **Definition of Blindness (NPCBVI):** Presenting distance visual acuity <3/60 in the better eye. * **Most Common Cause of Blindness in India:** Cataract (66.2%), followed by Corneal Opacity (7.4%). * **Most Common Cause of Childhood Blindness:** Vitamin A deficiency (historically) and Congenital Cataract/Anomalies (currently). * **WHO Goal:** The "Vision 2020" initiative aimed to reduce the prevalence of blindness to 0.3% by the year 2020.
Explanation: To establish the presence of endemic trachoma in a community, the World Health Organization (WHO) identifies specific clinical signs that indicate the disease is a public health problem. ### **Why Ectropion is the Correct Answer** **Ectropion** (outward turning of the eyelid margin) is **not** a feature of trachoma. In contrast, chronic cicatricial trachoma leads to **Entropion** (inward turning of the eyelid margin) due to subconjunctival fibrosis and scarring of the tarsal plate. This inward rotation causes the eyelashes to rub against the globe (Trichiasis), leading to corneal opacification and blindness. ### **Explanation of Incorrect Options** The following are classic clinical markers used to diagnose endemic trachoma: * **Herbert’s Pits:** These are pathognomonic shallow pits at the limbus formed by the healing of lymphoid follicles. Their presence is a definitive sign of past active trachoma. * **Conjunctival Scarring:** Chronic inflammation leads to Arlt’s line (horizontal scarring in the sulcus subtarsalis). This is a hallmark of the cicatricial stage. * **Vascular loops (Pannus):** Trachomatous pannus involves neovascularization and infiltration extending onto the upper part of the cornea. It is a key diagnostic feature of active and chronic disease. ### **NEET-PG Clinical Pearls** * **Causative Agent:** *Chlamydia trachomatis* (Serotypes A, B, Ba, and C). * **WHO SAFE Strategy:** **S**urgery (for trichiasis), **A**ntibiotics (Azithromycin), **F**acial cleanliness, **E**nvironmental improvement. * **WHO Grading (FISTO):** **F**ollicular, **I**ntense inflammation, **S**carring, **T**richiasis, **O**pacity. * **Vector:** The common housefly (*Musca sorbens*) is the primary vector.
Explanation: **Explanation:** **Correct Answer: A. Phacoemulsification** The most common cause of avoidable blindness globally and in India is **Cataract**. Under the National Programme for Control of Blindness and Visual Impairment (NPCBVI), cataract surgery is the primary focus of community ophthalmology. In a district hospital setting, **Phacoemulsification** (with IOL implantation) has become the standard of care and the most frequently performed procedure due to its high volume, rapid visual recovery, and minimal complications compared to older techniques like SICS. **Analysis of Incorrect Options:** * **B. Trabeculectomy:** This is the gold standard surgery for Glaucoma. While common, the prevalence of surgical glaucoma cases is significantly lower than cataract cases in a general district hospital setting. * **C. Bilateral Lamellar Tarsal Rotation (BLTR):** This is the surgery of choice for **Trachomatous Trichiasis**. While historically significant in community health, the prevalence of Trachoma has drastically declined in India due to the SAFE strategy, making it a rare procedure today. * **D. Dacrocystorhinostomy (DCR):** This is performed for chronic dacrocystitis (nasolacrimal duct obstruction). Although a common elective surgery, the volume does not match that of cataract surgeries. **High-Yield Clinical Pearls for NEET-PG:** * **NPCBVI Goal:** To reduce the prevalence of blindness to **0.25% by 2025**. * **Most Common Cause of Blindness (India):** Cataract (66.2%). * **Most Common Cause of Childhood Blindness:** Vitamin A deficiency (historically) and Congenital Cataract/Refractive errors (currently). * **Surgical Technique:** While Phacoemulsification is the most common in well-equipped district hospitals, **Manual Small Incision Cataract Surgery (MSICS)** remains the preferred technique for mass cataract camps due to cost-effectiveness and lack of dependence on expensive machinery.
Explanation: ### Explanation This question is based on the **Revised Guidelines for Evaluation and Assessment of Visual Impairment** (Gazette of India, 2018), which are crucial for certifying permanent disability in India. **Why 75% is the Correct Answer:** To determine the percentage of disability, we look at the **Best Corrected Visual Acuity (BCVA)** in the "Better Eye" and the "Worse Eye." * **Better Eye:** 6/60 (Categorized as Severe Visual Impairment) * **Worse Eye:** 1/60 (Categorized as Blindness/Profound Impairment) According to the standardized disability table: * If the better eye is **6/60 to 3/60** and the worse eye is **<3/60 to No Light Perception (NLP)**, the certified disability is **75%**. **Analysis of Incorrect Options:** * **A (100%):** Reserved for "Total Blindness" where the BCVA in the **better eye** is less than 3/60 or the field of vision is less than 10° in both eyes. * **C (50%):** Typically assigned when the better eye is 6/18 to 6/60 and the worse eye is 6/60 to 3/60. * **D (0%):** Assigned when the better eye is 6/6 to 6/12, even if the other eye has significant impairment (one-eyed patients with a normal fellow eye generally get 0-30% depending on the specific vision). **High-Yield Clinical Pearls for NEET-PG:** * **Definition of Blindness (NPCBVI):** BCVA <3/60 in the better eye (consistent with WHO criteria). * **Low Vision:** BCVA <6/18 to 3/60 in the better eye. * **Field of Vision:** If the field is <10° in the better eye, the patient is categorized as having 100% disability regardless of visual acuity. * **Certification:** Permanent disability certificates are issued only after the condition is stable and treated (medical/surgical) for at least 6 months.
Explanation: **Explanation:** The **Vision 2020: The Right to Sight** initiative, a global program launched by the WHO and IAPB, established a specific four-tier pyramidal model for eye care infrastructure in India to eliminate avoidable blindness. **1. Why Option A is the Correct Answer:** There is no designated tier called "Centers for Vision - 20." The highest level in the Vision 2020 infrastructure is the **Center of Excellence (Level 4)**. There are approximately **20** such centers planned for the country. These are premier institutes involved in training, high-end tertiary care, and policy-making. The nomenclature "Centers for Vision" is incorrect in the context of the official four-tier classification. **2. Analysis of Incorrect Options (The 4-Tier Model):** * **Option B (Training Centers - 200):** These are **Tertiary Level (Level 3)** centers. The goal is to have 200 such centers (1 per 5 million population) to provide specialized eye care and human resource training. * **Option C (Service Centers - 2000):** These are **Secondary Level (Level 2)** centers. The goal is 2,000 centers (1 per 500,000 population) equipped to perform surgeries like cataract extractions. * **Option D (Vision Centers - 20,000):** These are **Primary Level (Level 1)** centers. The goal is 20,000 centers (1 per 50,000 population) to provide basic eye care, refraction, and primary screening. **High-Yield Clinical Pearls for NEET-PG:** * **Target Diseases of Vision 2020:** Cataract, Trachoma, Onchocerciasis, Childhood Blindness, Refractive Errors, and Low Vision. (Note: Diabetic Retinopathy and Glaucoma were added later). * **NPCB Goal:** The National Programme for Control of Blindness (NPCB) aims to reduce the prevalence of blindness to **0.3%** by 2020 (Current prevalence is approx. 0.36% as per 2015-19 survey). * **Definition of Blindness (WHO):** Visual acuity < 3/60 in the better eye with best possible correction.
Epidemiology of Ocular Diseases
Practice Questions
Preventable Blindness
Practice Questions
Vision 2020 and Beyond
Practice Questions
School Eye Health Programs
Practice Questions
Screening Programs
Practice Questions
Eye Banking and Corneal Transplantation
Practice Questions
Primary Eye Care
Practice Questions
Rehabilitation of the Visually Impaired
Practice Questions
Eye Health Education
Practice Questions
National Programs for Eye Care
Practice Questions
Role of Non-Governmental Organizations
Practice Questions
Economics of Eye Care
Practice Questions
Telemedicine in Ophthalmology
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free